|
Real-time Estimate
Cboe BZX
22:38:06 06/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 100.37 USD | +0.67% |
|
+13.97% | -0.54% |
| 11-06 | Clorox Insider Bought Shares Worth $400,251, According to a Recent SEC Filing | MT |
| 11-04 | Deutsche Bank Adjusts Clorox Price Target to $99 From $95, Maintains Hold Rating | MT |
Company Valuation: The Clorox Company
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 17,352 | 19,661 | 16,948 | 14,799 | 11,541 | 12,078 | - | - |
| Change | - | 13.31% | -13.8% | -12.68% | -22.02% | 4.66% | - | - |
| Enterprise Value (EV) 1 | 19,880 | 21,821 | 19,231 | 17,120 | 16,465 | 17,019 | 16,864 | 16,665 |
| Change | - | 9.77% | -11.87% | -10.98% | -3.83% | 3.37% | -0.91% | -1.18% |
| P/E | 37.8x | 133x | 60.7x | 18.4x | 19.8x | 17.5x | 15.8x | 14.9x |
| PBR | 31.2x | 89.5x | 51.7x | 45.9x | 128x | 98.9x | 60.6x | 41.6x |
| PEG | - | -2x | 0.7x | 0x | -0.8x | 1x | 1.4x | 2.43x |
| Capitalization / Revenue | 2.44x | 2.66x | 2.39x | 2.08x | 1.72x | 1.58x | 1.55x | 1.51x |
| EV / Revenue | 2.8x | 2.95x | 2.71x | 2.41x | 2.45x | 2.23x | 2.16x | 2.08x |
| EV / EBITDA | 20.4x | 18.9x | 15x | 11.2x | 12.9x | 12x | 11.4x | 10.7x |
| EV / EBIT | 26.5x | 23.8x | 18.4x | 13x | 16x | 14.9x | 13.9x | 12.8x |
| EV / FCF | 37.2x | 23.5x | 39.8x | 22.5x | 18.7x | 18.5x | 19.1x | 15.6x |
| FCF Yield | 2.69% | 4.26% | 2.51% | 4.45% | 5.35% | 5.4% | 5.23% | 6.4% |
| Dividend per Share 2 | 4.66 | 4.72 | 4.8 | 4.88 | 4.96 | 5.018 | 5.267 | 5.466 |
| Rate of return | 3.31% | 2.97% | 3.52% | 4.06% | 5.2% | 5.03% | 5.28% | 5.48% |
| EPS 2 | 3.73 | 1.2 | 2.25 | 6.52 | 4.81 | 5.689 | 6.321 | 6.708 |
| Distribution rate | 125% | 393% | 213% | 74.8% | 103% | 88.2% | 83.3% | 81.5% |
| Net sales 1 | 7,107 | 7,389 | 7,093 | 7,104 | 6,720 | 7,636 | 7,812 | 8,024 |
| EBITDA 1 | 974 | 1,153 | 1,280 | 1,535 | 1,277 | 1,413 | 1,481 | 1,558 |
| EBIT 1 | 750 | 917 | 1,045 | 1,316 | 1,030 | 1,142 | 1,209 | 1,299 |
| Net income 1 | 462 | 149 | 280 | 810 | 587 | 690.9 | 754.4 | 815.6 |
| Net Debt 1 | 2,528 | 2,160 | 2,283 | 2,321 | 4,924 | 4,941 | 4,786 | 4,586 |
| Reference price 2 | 140.98 | 159.04 | 136.47 | 120.07 | 95.44 | 99.70 | 99.70 | 99.70 |
| Nbr of stocks (in thousands) | 123,080 | 123,624 | 124,188 | 123,253 | 120,921 | 121,147 | - | - |
| Announcement Date | 8/3/22 A | 8/2/23 A | 8/1/24 A | 7/31/25 A | 8/3/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 17.52x | 2.23x | 12.04x | 5.03% | 12.08B | ||
| 18.94x | 3.38x | 12.23x | 4.35% | 48.37B | ||
| 30.05x | 4.47x | 18.97x | 1.13% | 26.28B | ||
| 15.11x | 1.72x | 9.8x | 3.72% | 5.17B | ||
| 20.84x | 1.04x | 7.87x | 1.77% | 3.39B | ||
| 34.77x | 4.2x | 23.26x | - | 3.04B | ||
| 13.09x | 1.52x | 9.06x | 10.07% | 3.05B | ||
| 44.29x | 1.25x | 29.48x | 3.63% | 1.94B | ||
| Average | 24.33x | 2.47x | 15.34x | 4.24% | 12.92B | |
| Weighted average by Cap. | 22.24x | 3.29x | 14.21x | 3.63% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CLX Stock
- Valuation The Clorox Company
Select your edition
All financial news and data tailored to specific country editions
















